
Grand Pharma’s Innovative Product for Liver Tumors, Y-90, Is Commercialized in Mainland China, Empowering “Nuclear Power” to The Company’s Performance
HONG KONG SAR – Media OutReach – 20 June 2022 – On 19 June, the technology innovation pharmaceutical company, Grand Pharmaceutical Group Limited (stock code: […]












